Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Slides: 1–12 of 169
Symptoms, C. difficile Infection (CDI), diarrhea, pseudomembranous colitis, toxic megacolon, recurrence
Add to tray Remove from tray

Introduction: Symptoms of CDI

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: symptoms | C. difficile Infection (CDI) | diarrhea | pseudomembranous colitis | toxic megacolon | recurrence
Add to tray Remove from tray

Comparative Effectiveness of Diagnostic Assays for C.difficile

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: C. difficile Infection (CDI) | cell cytotoxicity assay | immunoassays | toxigenic culture | toxin gene detection | diagnostic assays
Add to tray Remove from tray

Assays Commonly Used in CDI Diagnostics

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: C. difficile Infection (CDI) | C. difficile culture | cytotoxicity assay | immunoassays | toxin gene detection | diagnostic assays
Add to tray Remove from tray

Comparative Effectiveness of Standard Antibiotic Treatment for CDI

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: antibiotic treatment | C. difficile Infection (CDI) | FDA-approved antibiotics | organism strain
Add to tray Remove from tray

Clinical Questions Addressed by the CER (1 of 2)

Presentation: Analgesics for Osteoarthritis—An Update
Keywords: comparative effectiveness | systematic review | key question
Add to tray Remove from tray

What To Discuss With Your Patients and Their Caregivers

Presentation: Analgesics for Osteoarthritis—An Update
Keywords: shared decisionmaking | patient discussions | benefits | adverse effects | nonopioid analgesics | patient values | patient preferences | symptoms
Add to tray Remove from tray

Gaps in Knowledge

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Keywords: gaps in knowledge | future research | subgroups | clinical trials
Add to tray Remove from tray

Background: Musculoskeletal Pain

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: musculoskeletal pain | children | clinical characteristics | stiffness | joint swelling | malar rash | cytopenia | pediatric rheumatic condition
Add to tray Remove from tray

Background: Pediatric Lupus Erythematosus

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: pediatric systemic lupus erythematosus | autoimmune disease | inflammation | blood vessels | connective tissues | organs | incidence | prevalence | disease progression | immunosuppression
Add to tray Remove from tray

Clinical Questions Addressed by the CER (1 of 3)

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: key questions | clinical questions | prevalence | incidence | natural history | musculoskeletal pain | children | adolescents
Add to tray Remove from tray

Gaps in Knowledge

Presentation: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Keywords: knowledge gaps | quality of life | psychosocial well-being | anxiety | undiagnosed musculoskeletal pain | serological tests | test performance | antinuclear antibody | cyclic-citrullinated peptide | rheumatoid factor | age | sex | race | ethnicity | recent infection
Add to tray Remove from tray

Comparative Effectiveness Review: Outcomes of Interest

Presentation: Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer
Keywords: adverse events | head and neck cancer | outcomes | quality of life | radiotherapy | tumor control | xerostomia | comparative effectiveness review
Pages: [1] 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
 
 
 
 
www.ahrq.gov AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364